ImportRefusal LogoImportRefusal

K.Boeun Pharmaceutical Co.,Ltd.

⚠️ Moderate Risk

FEI: 3016756938 • Pocheon, Gyeonggi • SOUTH KOREA

FEI

FEI Number

3016756938

📍

Location

Pocheon, Gyeonggi

🇰🇷
🏢

Address

114 Jangjagyeongje-Ro, Sinbung-Myeon, Pocheon, Gyeonggi, South Korea

Moderate Risk

FDA Import Risk Assessment

44.1
LowModerateHighCritical

This firm has a moderate history of FDA import refusals. Some attention may be warranted.

Statistics

2
Total Refusals
4
Unique Violations
5/8/2024
Latest Refusal
11/13/2020
Earliest Refusal

Score Breakdown

Violation Severity
70.0×40%
Refusal Volume
17.7×30%
Recency
51.2×20%
Frequency
5.7×10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity — AI-assessed (1-10)
  • 30% Refusal Volume — Logarithmic scale
  • 20% Recency — Decays over 5 years
  • 10% Frequency — Refusals per year

© ImportRefusal.com Original Analysis

Violation Summary

2231×

FALSE

The article is subject to refusal of admission pursuant to section 801(a)(3) in that it is a device whose labeling appears to be false or misleading.

271×

DRUG GMPS

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that the methods used in and controls used for the manufacture, processing, packing, or holding of drugs and other products do not appear to conform to current good manufacturing practices within the meaning of Section 501(a)(2)(B).

32801×

FRNMFGREG

The article is subject to refusal of admission pursuant to section 801(a)(3) in that it appears to be misbranded as defined in section 502(o) of the FD&C Act. It appears that it was manufactured, prepared, propagated, compounded, or processed in an establishment not duly registered under section 510 of the Act.

751×

UNAPPROVED

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).

Refusal History

DateProductViolationsDivision
5/8/2024
63RAY05SODIUM MONOFLUOROPHOSPHATE (DENTAL CARIES PROPHYLACTIC)
27DRUG GMPS
3280FRNMFGREG
Division of West Coast Imports (DWCI)
11/13/2020
62HBL05ETHYL ALCOHOL (ANTI-MICROBIAL)
223FALSE
75UNAPPROVED
Division of West Coast Imports (DWCI)

Frequently Asked Questions

What is K.Boeun Pharmaceutical Co.,Ltd.'s FDA import refusal history?

K.Boeun Pharmaceutical Co.,Ltd. (FEI: 3016756938) has 2 FDA import refusal record(s) in our database, spanning from 11/13/2020 to 5/8/2024.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. K.Boeun Pharmaceutical Co.,Ltd.'s FEI number is 3016756938.

What types of violations has K.Boeun Pharmaceutical Co.,Ltd. received?

K.Boeun Pharmaceutical Co.,Ltd. has been cited for 4 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about K.Boeun Pharmaceutical Co.,Ltd. come from?

All FDA import refusal data for K.Boeun Pharmaceutical Co.,Ltd. is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.